echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > From January 20 next year, over 40 selected drugs in centralized procurement will be renewed

    From January 20 next year, over 40 selected drugs in centralized procurement will be renewed

    • Last Update: 2021-12-25
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
     With the advancement of the normalization of volume procurement, the number of participating companies continues to increase
    .
    The industry believes that mass procurement is not only conducive to the large-scale operation of pharmaceutical companies, but also can further promote the professional division of labor and institutionalized competition among suppliers in all links from finished medicines to review, circulation and retail
    .
    Since the first bulk purchase of drugs at the end of 2018, six batches of centralized drug purchases have been carried out in China
    .
    Now that three years have passed, it is reported that the first round of the agreement for the selected drugs in the national centralized procurement has expired and the agreed purchase volume has been completed within the agreement period
    .
    The author was informed that on December 17, the Shanghai Sunshine Pharmaceutical Purchasing Network issued a notice on the renewal of selected drugs for the national centralized procurement part, announcing the renewal of 41 centralized procurement drugs for one year
    .
    The notice will be implemented on January 20, 2022
    .
    According to the notice, the first round of the agreement for the selected drugs in the national centralized procurement has expired, and the agreed purchase volume has been completed within the agreement period
    .
    According to the requirements of the National Drug Centralized Procurement Document for the procurement cycle of selected drugs, for products whose procurement cycle principle is 2 years, the Shanghai Pharmaceutical Institute will sign a tripartite agreement on the purchase and sale of selected drugs with related selected companies and their designated distribution companies.
    The agreement cycle is 1 year
    .
    According to the information form for renewal of selected drugs in the national centralized procurement part of the notice, it includes levocetirizine hydrochloride tablets from Hunan Jiudian Pharmaceutical Co.
    , Ltd.
    , Anastrozole tablets from Zhejiang Hisun Pharmaceutical Co.
    , Ltd.
    , and Jiangsu Jiayi Pharmaceutical Co.
    , Ltd.
    company apixaban sheet, Shanghai balance sine pharmaceutical Co.
    , Ltd.
    ambroxol hydrochloride capsules, Zhejiang Huahai Inc.
    olanzapine orally disintegrating tablets and the like including 41 drugs
    .
    According to combing, except for levocetirizine hydrochloride tablets as the second batch of selected drugs, the remaining 40 are the third batch of selected drugs
    .
    In addition to the aforementioned companies, Sinopharm Zhijun (Shenzhen) Pharmaceutical Co.
    , Ltd.
    , Hangzhou Kangenba Pharmaceutical Co.
    , Ltd.
    , Beijing Wanhui Shuanghe Pharmaceutical Co.
    , Ltd.
    , and Jiangsu Hengrui Pharmaceutical Co.
    , Ltd.
    Co.
    , Ltd.
    , etc.
    , a total of 29 companies
    .
    According to the industry, the drug collection has achieved certain results in more than three years.

    .
    For example, for production companies and distribution companies, centralized procurement helps to purify the industry ecology, increase the scale of intensive, and force upgrades and innovation; for patients and medical insurance, it improves the level of drug use, improves the efficiency of funds, and promotes in-depth medical reform
    .
    It is understood that on December 17th, in addition to the notice on the renewal of selected drugs in the national centralized procurement part issued by the Shanghai Sunshine Pharmaceutical Purchasing Network, on the same day, the Anhui Province Pharmaceutical Centralized Procurement Platform also issued the "About "Notice of Anhui Province on Issues concerning Concentrated Procurement of Partial Drugs in Bidding, Quotations, Price Negotiations, Selection of Supply Units, etc.
    "
    .
    According to the notice, Anhui Province purchased 45 drugs in this round of centralized drug procurement, and 169 companies were shortlisted for price review in the technical review
    .
    Judging from the 45 varieties collected this time, most of them are injection products.
    Among them, compound amino acids and diammonium glycyrrhizinate are purchased in large quantities
    .
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.